STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 61 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,630,000 | -56.2% | 1,258,224 | -50.0% | 1.16% | -65.4% |
| Q3 2019 | $6,011,000 | -24.6% | 2,515,072 | -1.3% | 3.33% | -17.1% |
| Q2 2019 | $7,972,000 | +71.4% | 2,546,997 | +172.7% | 4.02% | +97.5% |
| Q1 2019 | $4,651,000 | +10.7% | 933,876 | -0.4% | 2.04% | -6.2% |
| Q4 2018 | $4,202,000 | +104.4% | 937,900 | +121.3% | 2.17% | +89.3% |
| Q3 2018 | $2,056,000 | – | 423,846 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |